Erste Group Remains a Hold on Thermo Fisher (TMO)

In a report released yesterday, Hans Engel from Erste Group maintained a Hold rating on Thermo Fisher. The company’s shares closed yesterday at $491.46.

End of Quarter Sale - 50% Off TipRanks

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Engel covers the Healthcare sector, focusing on stocks such as Boston Scientific, Johnson & Johnson, and Merck & Company. According to TipRanks, Engel has an average return of 8.5% and a 53.70% success rate on recommended stocks.

In addition to Erste Group, Thermo Fisher also received a Hold from TipRanks – DeepSeek’s DeepSeek Medical – Diagnostics and Research in a report issued on March 24. However, on March 31, Bank of America Securities maintained a Buy rating on Thermo Fisher (NYSE: TMO).

Based on Thermo Fisher’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $12.22 billion and a net profit of $1.98 billion. In comparison, last year the company earned a revenue of $11.4 billion and had a net profit of $1.83 billion